Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California.
J Med Virol. 2020 Sep;92(9):1615-1628. doi: 10.1002/jmv.25866. Epub 2020 May 13.
We have applied mathematical modeling to investigate the infections of the ongoing coronavirus disease-2019 (COVID-19) pandemic caused by SARS-CoV-2 virus. We first validated our model using the well-studied influenza viruses and then compared the pathogenesis processes between the two viruses. The interaction between host innate and adaptive immune responses was found to be a potential cause for the higher severity and mortality in COVID-19 patients. Specifically, the timing mismatch between the two immune responses has a major impact on disease progression. The adaptive immune response of the COVID-19 patients is more likely to come before the peak of viral load, while the opposite is true for influenza patients. This difference in timing causes delayed depletion of vulnerable epithelial cells in the lungs in COVID-19 patients while enhancing viral clearance in influenza patients. Stronger adaptive immunity in COVID-19 patients can potentially lead to longer recovery time and more severe secondary complications. Based on our analysis, delaying the onset of adaptive immune responses during the early phase of infections may be a potential treatment option for high-risk COVID-19 patients. Suppressing the adaptive immune response temporarily and avoiding its interference with the innate immune response may allow the innate immunity to more efficiently clear the virus.
我们应用数学模型来研究由 SARS-CoV-2 病毒引起的正在进行的 2019 年冠状病毒病(COVID-19)大流行的感染情况。我们首先使用研究充分的流感病毒对模型进行了验证,然后比较了两种病毒的发病机制过程。宿主固有和适应性免疫反应之间的相互作用被认为是 COVID-19 患者病情更严重和死亡率更高的潜在原因。具体而言,两种免疫反应之间的时间不匹配对疾病进展有重大影响。COVID-19 患者的适应性免疫反应更有可能在病毒载量达到峰值之前出现,而流感患者则相反。这种时间上的差异导致 COVID-19 患者肺部易受伤害的上皮细胞耗竭延迟,而流感患者的病毒清除增强。COVID-19 患者更强的适应性免疫反应可能导致更长的恢复时间和更严重的继发性并发症。基于我们的分析,在感染的早期阶段延迟适应性免疫反应的开始可能是高危 COVID-19 患者的一种潜在治疗选择。暂时抑制适应性免疫反应并避免其与固有免疫反应相互干扰,可以使固有免疫更有效地清除病毒。